Evaluation of 225Ac/134Ce-Macropa-PEG4-YS5 as a novel theranostic pair for prostate cancer therapy

被引：0
|
作者：
Bobba, Kondapa [1 ]
Bidkar, Anil [1 ]
Wadhwa, Anju [2 ]
Meher, Niranjan [2 ]
Drona, Suchi [1 ]
Bidlingmaier, Scott [1 ]
Chan, Emily [1 ]
Greenland, Nancy Y. [1 ]
VanBrocklin, Henry [1 ]
Liu, Bin [1 ]
Flavell, Robert [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242306
引用
收藏
页数：3
相关论文
共 8 条
  • [1] Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5
    Bobba, Kondapa Naidu
    Bidkar, Anil P.
    Wadhwa, Anju
    Meher, Niranjan
    Drona, Suchi
    Sorlin, Alexandre M.
    Bidlingmaier, Scott
    Zhang, Li
    Wilson, David M.
    Chan, Emily
    Greenland, Nancy Y.
    Aggarwal, Rahul
    VanBrocklin, Henry F.
    He, Jiang
    Chou, Jonathan
    Seo, Youngho
    Liu, Bin
    Flavell, Robert R.
    THERANOSTICS, 2024, 14 (04): : 1344 - 1360
  • [2] Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac a-Radiotherapeutics
    Bobba, Kondapa Naidu
    Bidkar, Anil P.
    Meher, Niranjan
    Fong, Cyril
    Wadhwa, Anju
    Dhrona, Suchi
    Sorlin, Alex
    Bidlingmaier, Scott
    Shuere, Becka
    He, Jiang
    Wilson, David M.
    Liu, Bin
    Seo, Youngho
    VanBrocklin, Henry F.
    Flavell, Robert R.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1076 - 1082
  • [3] Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics
    Bobba, Kondapa
    Bidkar, Anil
    Meher, Niranjan
    Fong, Cyril
    Wadhwa, Anju
    Dhrona, Suchi
    Sorlin, Alexandre
    Bidlingmaier, Scott
    Shuere, Becka
    He, Jiang
    Wilson, David
    Liu, Bin
    Seo, Youngho
    VanBrocklin, Henry
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S11 - S12
  • [4] [225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [225Ac]Ac-PSMA-617
    Busslinger, Sarah D.
    Tschan, Viviane J.
    Richard, Olivia K.
    Talip, Zeynep
    Schibli, Roger
    Mueller, Cristina
    CANCERS, 2022, 14 (22)
  • [5] Treatment of prostate cancer xenografts with the targeted alpha-particle nanogenerator [225Ac]Ac-DOTA-YS5
    Bidkar, Anil
    Wang, Sinan
    Bobba, Kondapa
    Bidlingmaier, Scott
    Su, Yang
    Egusa, Emily
    Tang, Ryan
    Chou, Jonathan
    Aggarwal, Rahul
    He, Jiang
    Seo, Youngho
    Liu, Bin
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S31 - S31
  • [6] Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer
    Bobba, Kondapa
    Bidkar, Anil
    Wang, Sinan
    Bidlingmaier, Scott
    Tang, Ryan
    Su, Yang
    VanBrocklin, Henry
    Liu, Bin
    Seo, Youngho
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S53 - S53
  • [7] [134Ce]Ce-RPS-088 as a PET Imaging Surrogate for [225Ac]Ac-RPS-088 in a Model of Prostate Cancer: Early Preclinical Evaluation
    Wacker, Anja
    Azcona, Juan
    Lee, Chul-Hee
    Williams, Clarence
    Ponnala, Shashi
    Fung, Edward
    Wilson, Justin
    Babich, John
    Amor, Alejandro
    Kelly, James
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [8] Preclinical Evaluation of 225Ac-rhPSMA-10.1, a Novel Radiohybrid PSMA Compound for Targeted Alpha Therapy of Prostate Cancer
    Vassileva, V.
    Waldron, B.
    Wurzer, A.
    D'Alessandria, C.
    Gronlund, R. Veggerby
    Hallund, M. Wikke
    Gauden, D.
    Stevens, D.
    Foxton, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S65 - S66
1